FSD Pharma company info

What does FSD Pharma do?
FSD Pharma (CSE:HUGE), (FRA:0K9A), (NASDAQ:HUGE) focuses on the research and development of novel cannabinoid-based treatments aiming to improve the outcomes for individuals suffering from severe health conditions such as chronic pain and inflammation. The company's portfolio includes a variety of projects at different stages of clinical trials, demonstrating its commitment to innovation in the biomedical sector. FSD Pharma emphasizes the importance of creating effective, scientifically-backed treatment options to address unmet medical needs. Through its dedicated research efforts and strategic partnerships, FSD Pharma aims to become a key player in the development of breakthrough therapies that can enhance the quality of life for patients around the globe.
FSD Pharma  company media
Company Snapshot

Is FSD Pharma a public or private company?

key
Ownership
Public

How many people does FSD Pharma employ?

people
Employees
11

What sector is FSD Pharma in?

pie chart
Sector
Information Technology

Where is the head office for FSD Pharma ?

location pin
Head Office
Cobourg, Canada

What year was FSD Pharma founded?

founded flag
Year Founded
1994
What does FSD Pharma specialise in?
/Cannabinoid Pharmaceuticals /Medical Cannabis /Pain Management /Hydroponics Cultivation /Cancer Treatment /Palliative Care

What are the products and/or services of FSD Pharma ?

Overview of FSD Pharma offerings
Developing anti-inflammatory treatments targeting endocannabinoid receptors, focusing on diseases like irritable bowel syndrome.
Research in synthetic compounds aimed at treating autoimmune diseases such as multiple sclerosis.
Exploration of cannabinoid-based therapeutics for chronic pain management, leveraging non-opioid pathways.
Advancements in cancer care, particularly in cannabinoid therapies that potentially inhibit tumor growth.
Investment in technology platforms that improve the delivery mechanisms of cannabinoid medications.
Engagement in partnerships to expand research and development in psychedelic-based treatments for mental health disorders.

Who is in the executive team of FSD Pharma ?

FSD Pharma leadership team
  • Mr. Zeeshan  Saeed
    Mr. Zeeshan Saeed
    Founder, CEO, President & Executive Co-Chairman
  • Mr. Anthony John Durkacz
    Mr. Anthony John Durkacz
    Founder & Executive Co-Chairman
  • Mr. Nathan  Coyle CPA
    Mr. Nathan Coyle CPA
    Chief Financial Officer
  • Dr. Lakshmi P. Kotra BPHARM, Ph.D.
    Dr. Lakshmi P. Kotra BPHARM, Ph.D.
    CEO of Lucid & Director
  • Ms. Maryann  Adesso
    Ms. Maryann Adesso
    Corporate Secretary
  • Randell  Mack
    Randell Mack
    President of FSD BioSciences
  • Dr. Andrzej  Chruscinski M.D., Ph.D.
    Dr. Andrzej Chruscinski M.D., Ph.D.
    Vice President of Clinical & Scientific Affairs of Lucid
  • Mr. Kevin  Cassidy
    Mr. Kevin Cassidy
    Vice President of Quality-Lucid